Compare ARK Genomic Revolution ETF (ARKG) vs Byrna Technologies Inc (BYRN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Byrna Technologies Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Byrna Technologies Inc trades at $3.8 (market cap $87.71M). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Byrna Technologies Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | BYRN | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $27.63 |
52-Week Low | $23.09 | $3.87 |
Market Cap | — | $87.71M |
Enterprise Value | — | $79.32M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
BYRN trades at $3.865, down 1.9% today, with a bearish technical signal from moving averages and oscillators. Recent Q2 2026 results showed a significant revenue decline of 42.5% year-over-year and a net loss of $0.44 per share, missing estimates. The company faces challenges in sales and marketing effectiveness but is undertaking strategic initiatives including a recent acquisition and marketing overhaul to revive growth.
The outlook remains cautious due to persistent profitability issues and negative cash flow trends. While analyst consensus is predominantly Buy (71%), reflecting long-term potential in the less-lethal defense market, near-term risks from execution missteps and competitive pressures warrant careful monitoring. Investor sentiment is mixed amid ongoing operational reset efforts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Byrna Technologies Inc
Byrna Technologies specializes in less-lethal personal security devices. It develops and manufactures innovative handheld launchers and projectiles designed for self-defense, law enforcement, and private security use.
Read more on BYRN →
